Michael Gottschalk’s medical career began at the University of Health Sciences/The Chicago Medical School (now known as the Rosalind Franklin University of Medicine and Science) in Chicago, where he received his MD and PhD degrees. He did his pediatric internship and residency at UCLA Medical Center, where he served as an NIH Training Grant Fellow in Pediatric Endocrinology from 1987 to 1989.
Before joining UCSD, Dr. Gottschalk held faculty appointments at his alma mater and at the Loyola University, Chicago. In the last nine years Dr. Gottschalk has been Chief of the Pediatric Endocrinology and Diabetes Division at UCSD and Rady Children’s Hospital. For more than 15 years his research has focused on pediatric clinical trials in Type 1 and Type 2 diabetes.
In collaboration with immunologists, Dr. Gottschalk is investigating the change in T-cell populations during the early phase of diabetes to identify potential biomarkers. His lab is also working to understand which regulatory T-cell populations are effective in suppressing autoimmune T-cells that are targeted against beta cells.
Lim YH, Ovejero D, Sugarman JS, Deklotz CM, Maruri A, Eichenfield LF, Kelley PK, Jüppner H,
Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Bhattacharyya N, Guthrie LC, Gahl WA, Golas G, Loring EC, Overton JD, Mane SM, Lifton RP, Levy ML, Collins MT, Choate KA. (2014) Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 15;23(2):397-407.
Huang JS, Terrones L, Tompane T, Dillon L, Pian M,
Gottschalk M, Norman GJ, Bartholomew LK. (2014) Preparing Adolescents With Chronic Disease for Transition to Adult Care: A Technology Program. Pediatrics. May 19. pii: peds.2013-2830.
Kolodziejczyk JK, Gutzmer K, Wright SM, Arredondo EM, Hill L, Patrick K, Huang JS,
Gottschalk M, Norman GJ.(2014) Influence of specific individual and environmental variables on the relationship between body mass index and health-related quality of life in overweight and obese adolescents. Qual Life Res. Jul 1.
Griffin KJ, Thompson PA,
Gottschalk M, Kyllo JH, Rabinovitch A. (2014) Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. Sep;2(9):710-8.
Gottschalk ME, Newfield RS. (2014) Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia. Int J Pediatr Endocrinol. 2014(1):18.
Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015 Mar;135(3):424-34.
Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA; MS316 Study Group. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial. Horm Res Paediatr. 2015;83(4):268-79.
DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO,Holl RW, Hofer SE, Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep;167(3):627-32.e1-4.
Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ; T1D Exchange Clinic Network Metformin RCT Study Group. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 1;314(21):2241-50.